Dermatology Excimer Laser Market Size, Share and Growth Outlook, 2026

Dermatology Excimer Laser Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Dermatology Excimer Laser Market size is forecast to increase from $780.23 Million in 2026 to $1759.56 Million in 2034 at a CAGR of 10.7% between 2026 and 2034.

The Dermatology Excimer Laser market report provides detailed analysis and outlook of Dermatology Excimer Laser segments including By Product: (Tabletop Excimer Lasers, Hand-held Excimer Lasers, Trolley Mounted Excimer Lasers), By Application: (Psoriasis, Vitiligo, Atopic Dermatitis, Allergic Rhinitis, Alopecia Areata, Others), By End-User: (Hospitals, Dermatology Clinics, Plastic Surgery Centers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Dermatology Excimer Laser Industry Overview

Targeted Phototherapy Technologies Driving Clinical Adoption

The dermatology excimer laser industry continues to gain importance in the management of chronic inflammatory and pigmentary skin disorders, particularly psoriasis, vitiligo, and localized dermatological conditions that require highly targeted treatment approaches. Excimer laser systems utilize concentrated ultraviolet light, most commonly at a wavelength of 308 nm, to deliver precise phototherapy directly to affected skin while minimizing exposure to surrounding healthy tissue. The increasing demand for non-invasive dermatological treatments, combined with advancements in laser engineering and treatment optimization, is supporting the broader adoption of excimer laser technology across dermatology clinics and specialized treatment centers.

Regulatory Standards Enhancing Treatment Safety

Regulatory authorities are placing greater emphasis on performance validation and safety standards for high-energy ultraviolet laser systems. Updated technical standards issued by European Union medical device authorities have clarified testing requirements related to irradiance consistency for lasers used in targeted phototherapy applications. These requirements are particularly relevant for excimer laser platforms utilized in the treatment of psoriasis and vitiligo, where precise and consistent ultraviolet light delivery is essential for achieving therapeutic effectiveness while minimizing adverse effects. Enhanced regulatory oversight is encouraging manufacturers to improve system reliability, quality assurance protocols, and treatment accuracy throughout the dermatology excimer laser market.

Clinical Workflow Integration Improving Treatment Outcomes

Manufacturers are increasingly focusing on integrated treatment strategies that combine laser therapy with complementary dermatological interventions. Quantel Derma continues to promote its Excilite excimer laser system through clinical workflows that integrate targeted phototherapy with topical treatment regimens. The system emphasizes stable ultraviolet light delivery and precise lesion targeting while preserving healthy surrounding tissue. This approach reflects a broader industry trend toward personalized treatment protocols that maximize therapeutic response while reducing unnecessary skin exposure. The ability to selectively treat affected areas remains a key advantage supporting excimer laser adoption in dermatological practice.

Evidence-Based Protocols Advancing Vitiligo Management

Clinical research continues to refine treatment protocols and improve patient outcomes in excimer laser therapy. A study published in Lasers in Medical Science evaluated long-term remission rates among patients receiving 308-nm excimer laser treatment for localized vitiligo. The findings demonstrated that optimized pulse energy settings significantly improve pigmentation recovery, particularly in treatment-resistant cases. These results are influencing current clinical protocols by helping practitioners identify more effective treatment parameters. As evidence-based treatment strategies become increasingly important, ongoing research is supporting the development of standardized excimer laser protocols for dermatological conditions requiring targeted phototherapy.

Dermatology Excimer Laser Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Dermatology Excimer Laser market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Ra Medical Systems, Alma Lasers Ltd., STRATA Skin Sciences, Inc., Lumenis Be Ltd., Fotona d.o.o., Hologic, Inc., DEKA Research & Development Corporation, Shenzhen GSD Tech Co., Ltd., The Daavlin Company, Cutera, Inc.. The Dermatology Excimer Laser market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Dermatology Excimer Laser industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Dermatology Excimer Laser Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Dermatology Excimer Laser companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Dermatology Excimer Laser markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Dermatology Excimer Laser Market Competitive Benchmarking and Company Analysis

Leading companies in Dermatology Excimer Laser industry include- Ra Medical Systems, Alma Lasers Ltd., STRATA Skin Sciences, Inc., Lumenis Be Ltd., Fotona d.o.o., Hologic, Inc., DEKA Research & Development Corporation, Shenzhen GSD Tech Co., Ltd., The Daavlin Company, Cutera, Inc.. The Dermatology Excimer Laser market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Dermatology Excimer Laser Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Dermatology Excimer Laser market remains one of the strongest-performing segments in the country.
The US Dermatology Excimer Laser Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Dermatology Excimer Laser market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Dermatology Excimer Laser industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Dermatology Excimer Laser markets

Canada's strong Dermatology Excimer Laser sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Dermatology Excimer Laser market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Dermatology Excimer Laser Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Dermatology Excimer Laser market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Dermatology Excimer Laser population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Dermatology Excimer Laser industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Dermatology Excimer Laser market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Dermatology Excimer Laser sales through 2034

France Dermatology Excimer Laser companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Dermatology Excimer Laser Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Dermatology Excimer Laser distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Dermatology Excimer Laser Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Dermatology Excimer Laser market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Dermatology Excimer Laser industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Dermatology Excimer Laser industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Dermatology Excimer Laser Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Dermatology Excimer Laser market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Dermatology Excimer Laser market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Dermatology Excimer Laser Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Dermatology Excimer Laser Market Segmentation

By Product:
Tabletop Excimer Lasers
Hand-held Excimer Lasers
Trolley Mounted Excimer Lasers
By Application:
Psoriasis
Vitiligo
Atopic Dermatitis
Allergic Rhinitis
Alopecia Areata
Others
By End-User:
Hospitals
Dermatology Clinics
Plastic Surgery Centers

Top Companies in Dermatology Excimer Laser Industry

Ra Medical Systems
Alma Lasers Ltd.
STRATA Skin Sciences, Inc.
Lumenis Be Ltd.
Fotona d.o.o.
Hologic, Inc.
DEKA Research & Development Corporation
Shenzhen GSD Tech Co., Ltd.
The Daavlin Company
Cutera, Inc.

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025